News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,911 Results
Type
Article (23326)
Company Profile (114)
Press Release (242467)
Multimedia
Podcasts (51)
Webinars (4)
Section
Business (66591)
Career Advice (216)
Deals (11356)
Drug Delivery (39)
Drug Development (47766)
Employer Resources (19)
FDA (6376)
Job Trends (5030)
News (129447)
Policy (10570)
Tag
Academia (1329)
Academic (1)
Accelerated approval (15)
Adcomms (15)
Allergies (40)
Alliances (21906)
ALS (105)
Alzheimer's disease (757)
Antibody-drug conjugate (ADC) (246)
Approvals (6526)
Artificial intelligence (164)
Autoimmune disease (98)
Automation (15)
Bankruptcy (57)
Best Places to Work (4421)
BIOSECURE Act (6)
Biosimilars (119)
Biotechnology (93)
Bladder cancer (108)
Brain cancer (41)
Breast cancer (383)
Cancer (3554)
Cardiovascular disease (118)
Career advice (184)
Career pathing (6)
CAR-T (280)
CDC (4)
Cell therapy (759)
Cervical cancer (23)
Clinical research (39536)
Collaboration (849)
Company closure (3)
Compensation (263)
Complete response letters (26)
COVID-19 (1294)
CRISPR (69)
C-suite (305)
Cystic fibrosis (88)
Data (3539)
Denatured (9)
Depression (31)
Diabetes (171)
Diagnostics (2337)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (125)
Drug pricing (29)
Drug shortages (2)
Duchenne muscular dystrophy (114)
Earnings (24676)
Editorial (10)
Employer branding (2)
Employer resources (19)
Events (39656)
Executive appointments (350)
FDA (7680)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (10)
Funding (603)
Gene editing (141)
Generative AI (14)
Gene therapy (450)
GLP-1 (273)
Government (1257)
Grass and pollen (2)
Guidances (132)
Healthcare (6140)
HIV (19)
Huntington's disease (18)
IgA nephropathy (48)
Immunology and inflammation (146)
Immuno-oncology (28)
Indications (46)
Infectious disease (1383)
Inflammatory bowel disease (95)
Inflation Reduction Act (5)
Influenza (38)
Intellectual property (94)
Interviews (45)
IPO (5249)
IRA (6)
Job creations (826)
Job search strategy (153)
Kidney cancer (16)
Labor market (10)
Layoffs (197)
Leadership (3)
Legal (1757)
Liver cancer (67)
Longevity (9)
Lung cancer (602)
Lymphoma (349)
Machine learning (20)
Management (5)
Manufacturing (351)
MASH (42)
Medical device (2494)
Medtech (2508)
Mergers & acquisitions (6531)
Metabolic disorders (346)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (144)
Neuropsychiatric disorders (16)
Neuroscience (1279)
NextGen: Class of 2025 (1740)
Non-profit (1000)
Now hiring (10)
Obesity (128)
Opinion (81)
Ovarian cancer (125)
Pain (41)
Pancreatic cancer (121)
Parkinson's disease (133)
Partnered (16)
Patents (193)
Patient recruitment (218)
Peanut (15)
People (18677)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase I (14437)
Phase II (17908)
Phase III (11963)
Pipeline (2010)
Policy (52)
Postmarket research (926)
Preclinical (6624)
Press Release (57)
Prostate cancer (135)
Psychedelics (14)
Radiopharmaceuticals (140)
Rare diseases (443)
Real estate (1798)
Recruiting (8)
Regulatory (9460)
Reports (20)
Research institute (1330)
Resumes & cover letters (33)
Rett syndrome (12)
RNA editing (7)
RSV (21)
Schizophrenia (39)
Series A (99)
Series B (69)
Service/supplier (3)
Sickle cell disease (100)
Special edition (8)
Spinal muscular atrophy (107)
Sponsored (20)
Startups (1557)
State (1)
Stomach cancer (15)
Supply chain (29)
Tariffs (12)
The Weekly (41)
Vaccines (399)
Venture capital (32)
Weight loss (51)
Women's health (17)
Worklife (2)
Date
Today (55)
Last 7 days (247)
Last 30 days (1177)
Last 365 days (14096)
2025 (13797)
2024 (16444)
2023 (18542)
2022 (24788)
2021 (25064)
2020 (21737)
2019 (15147)
2018 (11481)
2017 (12932)
2016 (11807)
2015 (14333)
2014 (10156)
2013 (8429)
2012 (8662)
2011 (8728)
2010 (7711)
Location
Africa (213)
Alabama (21)
Alaska (3)
Arizona (57)
Arkansas (2)
Asia (30906)
Australia (4445)
California (4559)
Canada (1242)
China (746)
Colorado (129)
Connecticut (134)
Delaware (165)
Europe (41068)
Florida (509)
Georgia (102)
Hawaii (1)
Idaho (21)
Illinois (247)
India (39)
Indiana (83)
Iowa (13)
Japan (295)
Kansas (25)
Kentucky (7)
Louisiana (5)
Maine (55)
Maryland (578)
Massachusetts (3738)
Michigan (62)
Minnesota (152)
Mississippi (1)
Missouri (23)
Montana (10)
Nebraska (7)
Nevada (42)
New Hampshire (11)
New Jersey (1384)
New Mexico (15)
New York (1337)
North Carolina (495)
North Dakota (9)
Northern California (2227)
Ohio (128)
Oklahoma (8)
Oregon (8)
Pennsylvania (897)
Puerto Rico (4)
Rhode Island (20)
South America (297)
South Carolina (4)
Southern California (1752)
Tennessee (32)
Texas (847)
United States (16166)
Utah (121)
Virginia (120)
Washington D.C. (16)
Washington State (510)
Wisconsin (34)
265,911 Results for "gamida cell ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gamida Cell Presents Positive Initial Results on Treating Severe Aplastic Anemia (SAA) with Omidubicel
October 28, 2025
·
3 min read
Press Releases
Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
December 9, 2025
·
3 min read
Press Releases
Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
December 8, 2025
·
3 min read
Press Releases
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)
December 16, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
December 15, 2025
·
14 min read
Business
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, announced that it has entered into a Restructuring Support Agreement with certain funds managed by Highbridge Capital Management, LLC, the Company’s principal lender.
March 27, 2024
·
5 min read
Press Releases
FDA approves Omisirge(R) as First Approved Cell Therapy to Treat Severe Aplastic Anemia
December 8, 2025
·
3 min read
Business
Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
Gamida Cell Ltd. today announced that the company will release its financial results for the fourth quarter and full year ended December 31, 2023 and provide an update on the company on Wednesday, March 27, 2024.
March 22, 2024
·
1 min read
Press Releases
ProImmune Ltd Introduces ProVE® SL Self‑Loading MHC Class I Monomers to Improve T Cell Research Flexibility
October 30, 2025
·
2 min read
Business
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.
March 27, 2024
·
15 min read
1 of 26,592
Next
